Company profile CWBR
After 38 days of this quarter the interest is at 49.0. Based on that we can calculate that during remaining 53 days it will total up to 117.0. CohBar expected interest is significantly higher compared to same quarter last year (+95.0%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 96 | 82 -14.6% QoQ | 23 -72.0% QoQ | 123 434.8% QoQ |
| 2020 | 63 -34.4% YoY -48.8% QoQ | 149 81.7% YoY 136.5% QoQ | 149 547.8% YoY 0.0% QoQ | 81 -34.1% YoY -45.6% QoQ |
| 2021 | 225 257.1% YoY 177.8% QoQ | 187 25.5% YoY -16.9% QoQ | 389 161.1% YoY 108.0% QoQ | 418 416.0% YoY 7.5% QoQ |
| 2022 | 212 -5.8% YoY -49.3% QoQ | 93 -50.3% YoY -56.1% QoQ | 126 -67.6% YoY 35.5% QoQ | 97 -76.8% YoY -23.0% QoQ |
| 2023 | 60 -71.7% YoY -38.1% QoQ | 213 129.0% YoY 255.0% QoQ | 73 -42.1% YoY -65.7% QoQ | 134 38.1% YoY 83.6% QoQ |
| 2024 | 49 -18.3% YoY -63.4% QoQ | - | - | - |
The average 5 years interest of CohBar was 11.66 per week. The last year interest of CohBar compared to the last 5 years has changed by -17.5%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 34.17%.
After 39 days of this quarter the interest is at 342.0. Based on that we can calculate that during remaining 52 days it will total up to 798.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 558 | 717 28.5% QoQ | 632 -11.9% QoQ | 681 7.8% QoQ |
| 2020 | 882 58.1% YoY 29.5% QoQ | 723 0.8% YoY -18.0% QoQ | 710 12.3% YoY -1.8% QoQ | 584 -14.2% YoY -17.7% QoQ |
| 2021 | 760 -13.8% YoY 30.1% QoQ | 626 -13.4% YoY -17.6% QoQ | 561 -21.0% YoY -10.4% QoQ | 564 -3.4% YoY 0.5% QoQ |
| 2022 | 814 7.1% YoY 44.3% QoQ | 813 29.9% YoY -0.1% QoQ | 677 20.7% YoY -16.7% QoQ | 697 23.6% YoY 3.0% QoQ |
| 2023 | 891 9.5% YoY 27.8% QoQ | 744 -8.5% YoY -16.5% QoQ | 644 -4.9% YoY -13.4% QoQ | 752 7.9% YoY 16.8% QoQ |
| 2024 | 342 -61.6% YoY -54.5% QoQ | - | - | - |
The average 5 years interest of biotechnology was 55.07 per week. The last year interest of biotechnology compared to the last 5 years has changed by 3.36%. The interest for biotechnology is seasonal. The last year interest is comparable to 5 years ago. It has changed only by 1.53%.
There is not enough data for mitochondria therapeutics to provide analysis
There is not enough data for mitochondria therapeutics to provide correlation calculation
There is not enough data for mitochondria therapeutics to provide analysis
There is not enough data for peptides therapeutics to provide analysis
There is not enough data for peptides therapeutics to provide correlation calculation
There is not enough data for peptides therapeutics to provide analysis
There is not enough data for chronic diseases treatment to provide analysis
There is not enough data for chronic diseases treatment to provide correlation calculation
There is not enough data for chronic diseases treatment to provide analysis
There is not enough data for age-related diseases treatment to provide analysis
There is not enough data for age-related diseases treatment to provide correlation calculation
There is not enough data for age-related diseases treatment to provide analysis
There is not enough data for CB4211 clinical trial to provide analysis
There is not enough data for CB4211 clinical trial to provide correlation calculation
There is not enough data for CB4211 clinical trial to provide analysis
There is not enough data for nonalcoholic steatohepatitis treatment to provide analysis
There is not enough data for nonalcoholic steatohepatitis treatment to provide correlation calculation
There is not enough data for nonalcoholic steatohepatitis treatment to provide analysis
After 39 days of this quarter the interest is at 309.0. Based on that we can calculate that during remaining 52 days it will total up to 721.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 446 | 557 24.9% QoQ | 536 -3.8% QoQ | 543 1.3% QoQ |
| 2020 | 618 38.6% YoY 13.8% QoQ | 605 8.6% YoY -2.1% QoQ | 575 7.3% YoY -5.0% QoQ | 607 11.8% YoY 5.6% QoQ |
| 2021 | 606 -1.9% YoY -0.2% QoQ | 627 3.6% YoY 3.5% QoQ | 564 -1.9% YoY -10.0% QoQ | 613 1.0% YoY 8.7% QoQ |
| 2022 | 829 36.8% YoY 35.2% QoQ | 753 20.1% YoY -9.2% QoQ | 689 22.2% YoY -8.5% QoQ | 799 30.3% YoY 16.0% QoQ |
| 2023 | 867 4.6% YoY 8.5% QoQ | 837 11.2% YoY -3.5% QoQ | 749 8.7% YoY -10.5% QoQ | 907 13.5% YoY 21.1% QoQ |
| 2024 | 309 -64.4% YoY -65.9% QoQ | - | - | - |
The average 5 years interest of obesity treatment was 52.25 per week. The last year interest of obesity treatment compared to the last 5 years has changed by 21.78%. The interest for obesity treatment is trending. The last year interest is quite higher compared to 5 years ago. It has increased by 43.38%.
There is not enough data for CB5138 Analogs preclinical study to provide analysis
There is not enough data for CB5138 Analogs preclinical study to provide correlation calculation
There is not enough data for CB5138 Analogs preclinical study to provide analysis
After 39 days of this quarter the interest is at 78.0. Based on that we can calculate that during remaining 52 days it will total up to 182.0. idiopathic pulmonary fibrosis treatment expected interest is significantly lower compared to previous quarter (-46.3%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 118 | 135 14.4% QoQ | 101 -25.2% QoQ | 131 29.7% QoQ |
| 2020 | 152 28.8% YoY 16.0% QoQ | 147 8.9% YoY -3.3% QoQ | 289 186.1% YoY 96.6% QoQ | 98 -25.2% YoY -66.1% QoQ |
| 2021 | 182 19.7% YoY 85.7% QoQ | 259 76.2% YoY 42.3% QoQ | 280 -3.1% YoY 8.1% QoQ | 126 28.6% YoY -55.0% QoQ |
| 2022 | 195 7.1% YoY 54.8% QoQ | 119 -54.1% YoY -39.0% QoQ | 71 -74.6% YoY -40.3% QoQ | 101 -19.8% YoY 42.3% QoQ |
| 2023 | 184 -5.6% YoY 82.2% QoQ | 239 100.8% YoY 29.9% QoQ | 216 204.2% YoY -9.6% QoQ | 339 235.6% YoY 56.9% QoQ |
| 2024 | 78 -57.6% YoY -77.0% QoQ | - | - | - |
The average 5 years interest of idiopathic pulmonary fibrosis treatment was 13.64 per week. The last year interest of idiopathic pulmonary fibrosis treatment compared to the last 5 years has changed by 34.38%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 84.04%.
There is not enough data for fibrotic diseases treatment to provide analysis
There is not enough data for fibrotic diseases treatment to provide correlation calculation
There is not enough data for fibrotic diseases treatment to provide analysis